GIBU
NKTR icon

Gulf International Bank (UK)’s Nektar Therapeutics NKTR Stock Holding History

Gulf International Bank (UK)’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,576
Closed -$703K – 740
2019
Q3 		$703K Hold
2,576
– – 0.01% 614
2019
Q2 		$1.37M Hold
2,576
– – 0.02% 566
2019
Q1 		$1.3M Hold
2,576
– – 0.02% 554
2018
Q4 		$1.27M Sell
2,576
-1,100
-30% -$664K 0.03% 537
2018
Q3 		$3.36M Buy
3,676
+147
+4% +$125K 0.04% 444
2018
Q2 		$2.58M Buy
+3,529
New +$4.07M 0.03% 544

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Gulf International Bank (UK)'s NKTR Position: Q4 2019 in Review

Gulf International Bank (UK) sold out of Nektar Therapeutics (NKTR) in Q4 2019, closing a stake of 2,576 shares — an estimated $703K sold.

Gulf International Bank (UK) first reported a position in NKTR in Q2 2018 and held it in 6 quarters. The position peaked at $3.36M in Q3 2018. 281 funds tracked by Wall St. Rank hold NKTR as of Q4 2019.

  • Gulf International Bank (UK) reported no remaining Nektar Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Gulf International Bank (UK) sold 2,576 Nektar Therapeutics shares in Q4 2019, an estimated $703K.
  • Gulf International Bank (UK) first reported a position in Nektar Therapeutics in Q2 2018 and held it in 6 quarters.
  • Gulf International Bank (UK)'s Nektar Therapeutics position peaked at $3.36M in Q3 2018.
  • 281 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2019.

Based on Gulf International Bank (UK)'s 13F filing for Q4 2019, filed 5 Feb 2020.